<DOC>
	<DOCNO>NCT00383305</DOCNO>
	<brief_summary>This research study head cool . Its goal determine whether cool baby ' head reduce prevent brain damage may result temporarily reduce oxygen supply brain . In study , half baby ( select random ) special cool cap circulate water place head 72 hour low temperature brain . The rest baby 's body maintain defined temperature standard overhead radiant heater . The study protocol include take analysis blood sample , performance brain wave test , image brain ultrasound , test clinically indicate . Neurodevelopmental outcome also assess 18 month age .</brief_summary>
	<brief_title>CoolCap Trial , Treatment Perinatal Hypoxic-Ischemic Encephalopathy</brief_title>
	<detailed_description>The objective study determine whether head cool mild systemic hypothermia term infant follow perinatal asphyxia safe procedure improve survival without neurodevelopmental disability . Outcome assess survival neurological neurodevelopmental test 18 month age . Within 6 hour birth , infant randomize either non-cooled control group rectal temperature keep 37+/-0.5 degC head cool mild systemic hypothermia follow . A cooling device capable circulate cool water temperature-regulated manner cap fit around infant 's scalp cool head . The core rectal temperature infant maintain 34.5+/-0.5 degC adjust cap water temperature . The infant 's rectal , nasopharyngeal , scalp ( fontanel ) , skin ( abdominal ) temperatures continuously monitor . Also , metabolic , cardiovascular , pulmonary coagulation laboratory measurement assess predefined time point . Cooling maintain 72 hour , follow four hour rewarming , goal raise rectal temperature normal body temperature 0.5 degC per hour . The outcome measure severe neurodevelopmental disability survival rate 18 month age assess blind , independent observer .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Hypoxia-Ischemia , Brain</mesh_term>
	<criteria>Infants assess sequentially criterion A , B C list . Infant must meet three criterion eligible trial enrollment . Criteria A : Infants &gt; = 36 week gestation admit NICU ONE following : Apgar score &lt; = 5 10 minute birth ; Continued need resuscitation , include endotracheal mask ventilation , 10 minute birth ; Acidosis define either umbilical cord pH arterial pH within 60 minute birth &lt; 7.00 ; Base Deficit &lt; = 16 mmol/L umbilical cord blood sample OR blood sample within 60 minute birth ( arterial venous blood ) . Criteria B : Moderate severe encephalopathy consisting alter state consciousness ( show lethargy , stupor , coma ) AND least one following : Hypotonia ; Abnormal reflex , include oculomotor pupillary abnormality ; An absent weak suck ; Clinical seizures Criteria C : At least 20 minute duration amplitude integrated EEG ( aEEG/CFM ) recording show abnormal background aEEG/CFM activity seizure . The aEEG/CFM perform one hour age . If subsequently abnormal aEEG/CFM record 5.5 hour age , infant eligible enrollment . The aEEG perform within 30 minute IV anticonvulsant therapy may cause suppression EEG activity . In particular , high dose prophylactic anticonvulsant therapy ( e.g. , &gt; 20 mg/kg phenobarbitone ) give prior perform aEEG/CFM . Infant expect &gt; 5.5 hour age time randomization Prophylactic administration high dose anticonvulsant ( e.g. , &gt; 20 mg/kg phenobarbitone ) . After trial entry phenobarbitone anticonvulsant therapy allow give clinically indicated treat seizure . Major congenital abnormality , diaphragmatic hernia require ventilation , congenital abnormality suggestive chromosomal anomaly syndrome include brain dysgenesis Imperforate anus Evidence head trauma skull fracture cause major intracranial hemorrhage Infant &lt; 1,800 g birth weight Head circumference &lt; ( mean 2SD ) gestation birth weight length &gt; ( mean 2SD ) Infant `` extremis '' ( i.e . infant additional intensive management would offer judgment attend neonatologist ) Unavailability essential equipment ( e.g. , CoolCap , aEEG/CFM ) Planned concurrent participation experimental treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Hours</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>neonatal</keyword>
	<keyword>hypoxic</keyword>
	<keyword>ischemic</keyword>
	<keyword>encephalopathy</keyword>
	<keyword>HIE</keyword>
	<keyword>birth asphyxia</keyword>
	<keyword>neonatal encephalopathy</keyword>
	<keyword>Asphyxia Neonatorum</keyword>
	<keyword>hypothermia , therapeutic</keyword>
	<keyword>brain cooling</keyword>
	<keyword>selective head cool</keyword>
</DOC>